Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 1
2016 1
2017 2
2019 3
2020 3
2021 5
2022 11
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Antibody Response to Breakthrough SARS-CoV-2 Infection in "Booster" Vaccinated Patients with Multiple Myeloma According to B/T/NK Lymphocyte Absolute Counts and anti-CD38 Treatments.
Sgherza N, Mestice A, Larocca AMV, Musto P. Sgherza N, et al. Among authors: larocca amv. Mediterr J Hematol Infect Dis. 2024 Mar 1;16(1):e2024022. doi: 10.4084/MJHID.2024.022. eCollection 2024. Mediterr J Hematol Infect Dis. 2024. PMID: 38468827 Free PMC article. No abstract available.
Humoral Immune Response after anti-SARS-CoV-2 Vaccine "Booster" Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS).
Sgherza N, Curci P, Rizzi R, Larocca AMV, Vimercati L, Tafuri S, Chironna M, Musto P. Sgherza N, et al. Among authors: larocca amv. Mediterr J Hematol Infect Dis. 2023 Jan 1;15(1):e2023011. doi: 10.4084/MJHID.2023.011. eCollection 2023. Mediterr J Hematol Infect Dis. 2023. PMID: 36660353 Free PMC article. No abstract available.
Antispike Immunoglobulin-G (IgG) Titer Response of SARS-CoV-2 mRNA-Vaccine (BNT162b2): A Monitoring Study on Healthcare Workers.
Inchingolo AD, Malcangi G, Ceci S, Patano A, Corriero A, Azzollini D, Marinelli G, Coloccia G, Piras F, Barile G, Settanni V, Mancini A, De Leonardis N, Garofoli G, Palmieri G, Isacco CG, Rapone B, Jones M, Bordea IR, Tartaglia GM, Scarano A, Lorusso F, Macchia L, Larocca AMV, Tafuri S, Migliore G, Brienza N, Dipalma G, Inchingolo F. Inchingolo AD, et al. Among authors: larocca amv. Biomedicines. 2022 Sep 26;10(10):2402. doi: 10.3390/biomedicines10102402. Biomedicines. 2022. PMID: 36289664 Free PMC article.
Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast.
Inchingolo AD, Malcangi G, Ceci S, Patano A, Corriero A, Vimercati L, Azzollini D, Marinelli G, Coloccia G, Piras F, Barile G, Settanni V, Mancini A, De Leonardis N, Garofoli G, Palmieri G, Isacco CG, Rapone B, Scardapane A, Curatoli L, Quaranta N, Ribezzi M, Massaro M, Jones M, Bordea IR, Tartaglia GM, Scarano A, Lorusso F, Macchia L, Larocca AMV, Aityan SK, Tafuri S, Stefanizzi P, Migliore G, Brienza N, Dipalma G, Favia G, Inchingolo F. Inchingolo AD, et al. Among authors: larocca amv. Int J Mol Sci. 2022 Jul 30;23(15):8485. doi: 10.3390/ijms23158485. Int J Mol Sci. 2022. PMID: 35955621 Free PMC article. Review.
Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients.
Sgherza N, Zucano S, Vitucci A, Palma A, Tarantini F, Campanale D, Vimercati L, Larocca AMV, Visceglie D, Acquafredda A, Ostuni A, Di Gennaro D, Vitucci C, Tafuri S, Musto P. Sgherza N, et al. Among authors: larocca amv. Mediterr J Hematol Infect Dis. 2022 Jul 1;14(1):e2022056. doi: 10.4084/MJHID.2022.056. eCollection 2022. Mediterr J Hematol Infect Dis. 2022. PMID: 35865398 Free PMC article. No abstract available.
Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by SARS-CoV-2 infection: An Italian prospective observational study.
Stefanizzi P, Larocca AMV, Martinelli A, Soldano S, Dell'Aera M, Migliore G, Germinario CA, Vimercati L, Tafuri S, Bianchi FP. Stefanizzi P, et al. Among authors: larocca amv. Vaccine. 2022 Mar 15;40(12):1805-1809. doi: 10.1016/j.vaccine.2022.02.002. Epub 2022 Feb 16. Vaccine. 2022. PMID: 35190212 Free PMC article.
29 results